Stelara

AstraZeneca drops Skyrizi rival after seeing R&D timeline spiral
AstraZeneca drops Skyrizi rival after seeing R&D timeline spiral
Fierce Biotech
AstraZeneca
IBD
AbbVie
JNJ
brazikumab
Skyrizi
Stelara
Flag link:
Amgen settles patent lawsuit over biosimilar of J&J's big-selling Stelara
Amgen settles patent lawsuit over biosimilar of J&J's big-selling Stelara
Yahoo/Reuters
JNJ
Amgen
patents
Stelara
biosimilars
legal
Flag link:
Acquired patents aid J&J defense of top-selling drug from biosimilar challenge
Acquired patents aid J&J defense of top-selling drug from biosimilar challenge
BioPharma Dive
Amgen
JNJ
Stelara
psoriasis
patents
biosimilars
Flag link:
Citing J&J's 'failure to comply' with court rules, judge nixes early bid to block Amgen's Stelara biosim
Citing J&J's 'failure to comply' with court rules, judge nixes early bid to block Amgen's Stelara biosim
Fierce Pharma
JNJ
patents
Janssen
Amgen
biosimilars
Stelara
Flag link:
J&J reiterates 2025 sales goal despite looming Stelara exclusivity loss, global economic challenges
J&J reiterates 2025 sales goal despite looming Stelara exclusivity loss, global economic challenges
Endpoints
JNJ
revenue
earnings
Stelara
Flag link:
J&J sues Amgen over plan to sell drug similar to Stelara
J&J sues Amgen over plan to sell drug similar to Stelara
Business Insurance
JNJ
Janssen
Amgen
legal
ulcerative colitis
patents
Stelara
Flag link:
J&J nabs label expansion for Stelara in pediatric psoriatic arthritis
J&J nabs label expansion for Stelara in pediatric psoriatic arthritis
Endpoints
JNJ
Stelara
pediatric
psoriatic arthritis
Flag link:
The patent winter is coming
The patent winter is coming
EP Vantage
patents
biosimilars
patent cliff
Keytruda
Opdivo
Eliquis
Darzalex
Revlimid
Humira
Stelara
AbbVie
Merck
Bristol Myers Squibb
JNJ
Flag link:
J&J's crown jewel Stelara faces another potential rival as biosim player Alvotech touts trial win
J&J's crown jewel Stelara faces another potential rival as biosim player Alvotech touts trial win
Fierce Pharma
Alvotech
Teva Pharmaceutical
JNJ
Stelara
AVT04
biosimilars
psoriasis
Flag link:
Could This Biosimilar Drug Candidate Create a Blockbuster for Amgen?
Could This Biosimilar Drug Candidate Create a Blockbuster for Amgen?
Motley Fool
Amgen
biosimilars
Stelara
JNJ
Flag link:
Janssen, Brickell and ViiV are Knocking on FDA's Door
Janssen, Brickell and ViiV are Knocking on FDA's Door
BioSpace
FDA
Janssen
Stelara
juvenile psoriatic arthritis
Brickell Bio
sofpironium bromide gel
ViiV Healthcare
HIV
Triumeq
Flag link:
The top 15 blockbuster patent expirations coming this decade
The top 15 blockbuster patent expirations coming this decade
Fierce Pharma
patents
patent cliff
AbbVie
Humira
Merck
Keytruda
Bristol Myers Squibb
Revlimid
Pfizer
Eliquis
Regeneron
Eylea
JNJ
Stelara
Opdivo
GSK
Dolutegravir
Ibrance
Januvia
Eli Lilly
Trulicity
Novo Nordisk
Victoza
Amgen
Prolia
Xgeva
Novartis
Cosentyx
Takeda
Entyvio
Flag link:
J&J scraps late-stage study testing Stelara for lupus
J&J scraps late-stage study testing Stelara for lupus
Reuters
JNJ
Janssen
lupus
Stelara
clinical trials
Flag link:
Janssen trials ultrasound-guided approach to treating Crohn’s
Janssen trials ultrasound-guided approach to treating Crohn’s
Pharmaforum
JNJ
Janssen
guided ultrasound
Stelara
Crohn's Disease
Flag link:
Janssen’s Stelara Wins FDA Approval for Ulcerative Colitis
Janssen’s Stelara Wins FDA Approval for Ulcerative Colitis
BioSpace
JNJ
Janssen
Stelara
FDA
ulcerative colitis
Flag link:
UCB's bispecific beats J&J's Stelara in psoriasis phase 3
UCB's bispecific beats J&J's Stelara in psoriasis phase 3
Fierce Biotech
UCB Pharma
bispecific antibodies
bimekizumab
JNJ
Stelara
psoriasis
Flag link:
Prescription drugs boost drives J&J forecasts higher, shares rise
Prescription drugs boost drives J&J forecasts higher, shares rise
Yahoo/Reuters
JNJ
earnings
Stelara
Imbruvica
Flag link:
J&J gets Stelara okay in Europe for ulcerative colitis
J&J gets Stelara okay in Europe for ulcerative colitis
Pharmaforum
JNJ
Stelara
Janssen
Europe
Flag link:
Most people pay less than $5 per month for the drug. But some pay $11,002
Most people pay less than $5 per month for the drug. But some pay $11,002
Stat
JNJ
Janssen
Stelara
drug pricing
Flag link:
Stelara Shines in Three Year Crohn's Disease Study
Stelara Shines in Three Year Crohn's Disease Study
CP Wire
Janssen
JNJ
Stelara
Crohn's Disease
clinical trials
Flag link:

Pages